Differential Study of Invasive Pituitary Adenomas in the Sellar and Cavernous Sinus Regions

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorShanghai Zhongshan Hospital

About this trial

This study involves collecting paired tumor samples from intrasellar and cavernous sinus regions of 20 invasive pituitary tumor patients, preserving them at -80°C for quality multi-omics analysis. Proteomics and transcriptomics are employed to identify molecular differences, while imaging data (MRI/CT) assesses tumor morphology and invasion. In vitro experiments and mechanistic studies validate key findings, exploring how regional molecular differences affect tumor behavior. Data integration combines multi-omics and imaging features to uncover biomarkers and pathways associated with invasiveness and regional specificity, with statistical analysis ensuring significance and reliability.

Eligibility criteria

Qualifiers

Invasive pituitary tumors involving the cavernous sinus

Retrospective inclusion of patients who have signed informed consent forms for the donation of biological samples and health-related information

Age range: 18-80 years

Subjects are willing to participate in this study

Disqualifiers

Non-invasive pituitary tumors

Pregnant or breastfeeding

Other conditions deemed unsuitable for participation in this clinical trial as assessed by the physician

Trial design

Treatments tested in this trial

  • surgery

Treatment groups

20 Participants
are divided into 2 treatment groups

Sponsors and collaborators